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A pilot study was conducted to determine if host genetic factors influence susceptibility and outcomes in human filariasis.
Using the candidate gene approach, a well-characterized population in South India was studied using common
polymorphisms in six genes (CHIT1, MPO, NRAMP, CYBA, NCF2, and MBL2). A total of 216 individuals from South India
were genotyped; 67 normal (N), 63 asymptomatic microfilaria positive (MF+), 50 with chronic lymphatic
dysfunction/elephantiasis (CP), and 36 tropical pulmonary eosinophilia (TPE). An association was observed between the
HH variant CHIT1 genotype, which correlates with decreased activity and levels of chitotriosidase and susceptibility to
filarial infection (MF+ and CP; P = 0.013). The heterozygosity of CHIT1 gene was over-represented in the normal
individuals (P = 0.034). The XX genotype of the promoter region in MBL2 was associated with susceptibility to filariasis
(P = 0.0093). Since analysis for MBL-sufficient vs insufficient haplotypes was not informative, it is possible the MBL2
promoter association results from linkage disequilibrium with neighboring loci. We have identified two polymorphisms,
CHIT1 and MBL2 that are associated with susceptibility to human filarial infection, findings that merit further follow-up in a
larger study. Genes and Immunity (2001) 2, 248–253.
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Introduction
Lymphatic filariasis, caused by one of the three lymph-
dwelling filariae, Wuchereria bancrofti, Brugia malayi, or
Brugia timori, infects 129 million people throughout the
tropics and subtropics with W. bancrofti being the most
predominant.1,2 Each of these filarial parasites goes
through a complex life cycle that includes infective larvae
carried by mosquitoes, adult worms found in the lymph
node or in the adjacent lymphatics, and their offspring
(microfilariae) that circulate in the blood, often with noc-
turnal periodicity. Among the varied (and occasionally
overlapping) clinical manifestations of lymphatic filari-
asis are a subclinical condition associated with micro-
filaremia (asymptomatic microfilaremia; MF+), chronic
lymphatic obstruction/elephantiasis or hydrocele, collec-
tively also known as chronic pathology (CP) and the rare
condition, tropical pulmonary eosinophilia (TPE). The
pathogenesis of the lymphatic condition of filarial infec-
Correspondence: Stephen J Chanock, MD, Immunocompromised Host Sec-
tion, Pediatric Oncology Branch, National Cancer Institute, Advanced
Technology Center, 8717 Grovemont Circle, Gaithersburg, MD 20877,
USA. E-mail: sc83anih.gov
3Current address: Division of Geographic Medicine, Case Western
Reserve University, Cleveland, Ohio, USA
Received 17 November 2000; revised and accepted 19 April 2001
tion is complex and probably involves both inflammatory
processes that are immune-mediated and secondary bac-
terial infections superimposed on lymphatic dysfunc-
tion.3
The mapping of the human genome has created a rich
resource for annotating differences in populations. Many
different genes with allelic variations are believed to con-
tribute to disease outcomes, especially common infec-
tious and autoimmune disorders.4 Currently, there is a
major effort to identify and characterize common variants
in known genes, commonly known as polymorphisms.5–7
In particular, there has been growing interest in whether
human genetic polymorphisms in host defense pathways
could affect susceptibility to helminth infection and the
likelihood of developing particular clinical manifes-
tations. Epidemiological studies in areas where filariasis
is endemic have revealed differential susceptibilities to
infection, both within entire populations as well as within
families.8 Although the cause of differential susceptibility
to clinical expression of helminth infections has only been
addressed in a few human studies, early studies impli-
cated the major histocompatibility complex (MHC).9–14
Several large-scale studies have attempted to make more
compelling the argument of an underlying genetic sus-
ceptibility for disease outcome in both filarial and schisto-
some infection. For example, in schistosomiasis, genetic
loci for susceptibility and resistance have been physically
mapped.15–21
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the host genetic contribution to acquisition and outcomes
in human filarial infection, we performed a pilot study,
utilizing a candidate gene approach. The chosen genes
fulfilled the following criteria: a frequency of greater than
5% of at least one polymorphic variant in one or more
populations, in vitro evidence of the biological signifi-
cance of the variant and prior clinical studies suggesting
a role in disease susceptibility or outcome. Each of the
genes is a critical component of host defense microbicidal
pathway, such as two components of the oxygen depen-
dent NADPH-oxidase, p22-phox (CYBA)22,23 and p67-
phox (NCF2), myeloperoxidase (MPO),24 Nramp-1
(NRAMP),25 or a phagocyte specific chitotriosidase
(CHIT1).26,27 In addition, we studied the C-type collectin,
mannose-binding lectin (MBL2).28,29 In our preliminary
investigation of genetic factors that influence expression
of human lymphatic filariasis, we analyzed the distri-
bution of genetic polymorphisms of the candidate genes
against three major clinical outcomes following exposure
to filarial parasites in a W. bancrofti-endemic area of
South India.
Results
In the first phase, we analyzed the distribution of variant
genotypes of the six candidate genes and compared the
uninfected normal group (N) individually with infected
individuals with either of the two major manifestations
of lymphatic filarial infection (MF+ and CP) (see Table
1). For the purpose of examining susceptibility to infec-
tion, the N group was compared to MF+ and CP together;
samples had been collected as part of a population based
study of filarial infection in South India.3 A significant
difference was observed at the locus for CHIT1 (2 = 8.06;
P = 0.018). Analysis by individual genotypes was
revealing for the comparison of N to MF+ and CP.
Together, both the HH and HT genotypes differed (P =
0.013 and 0.034, respectively). In particular, individuals
homozygous for the H allele were over-represented in the
group who acquired filarial infection. Previously, the HH
genotype has been shown to be associated with
decreased production and enzymatic activity of the
human phagocytic chitinase.27 The HT genotype was
over-represented in normal individuals. However, the
CHIT1 genotype does not influence susceptibility to one
of the specific manifestations of infection with W.
bancrofti in South India, MF+ or CP, respectively.
Analysis of two polymorphisms in the mannose-bind-
ing protein gene, MBL2, which have been reported to be
linked, revealed an unexpected finding. The distribution
of structural variants, known as B, C and D alleles of exon
1 in infected vs uninfected subjects did not differ statisti-
cally (see Table 2). Analysis was performed for each of
the three individual variants as well as the presence of
at least one of the structural variants, B, C or D (data not
shown).28 Interestingly, we examined the polymorphism
in the proximal promoter region (−221 bp), known as the
X/Y locus29 and found that the XX genotype, which is
correlated with significantly lower circulating levels of
the mannose-binding lectin, is under-represented in the
infected population (P = 0.004). However, we did not find
a significant association for susceptibility to infection
when analyzed by MBL-sufficient and MBL-insufficient
haplotypes (see Table 2 and its legend). Our study did
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Table 1 Genotype distribution of five study genes in uninfected
and infected (asymptomatic microfilaremia (MF+) and chronic lym-
phatic obstruction/elephantiasis (CP)) subjects in South India
Genotypes Normal Infected group P values N vs
(N) (MF+ and CP) (MF+ and CP)
(n = 67) (n = 113)
Locus Genotype
CHIT1
HH 7 (10%) 30 (27%) 0.013 (f)
HT 39 (58%) 46 (41%) 0.018 0.034
TT 21 (31%) 37 (32%) 0.98
MPO
AA 2 (3%) 0 (0%) 0.14 (f)
AG 12 (18%) 26 (23%) 0.14 0.53
GG 53 (79%) 87 (77%) 0.89
NRAMP
GC 13 (20%) 22 (20%) 0.98GG 53 (80%) 89 (80%)
CYBA
CC 23 (35%) 50 (45%) 0.26
TC 33 (50%) 53 (47%) 0.22 0.85
TT 10 (15%) 9 (8%) 0.22
NCF2 (−149)
AA 0 (0%) 1 (1%) 1.0 (f)
AG 5 (8%) 10 (9%) 0.70 1.0 (f)
GG 61 (92%) 100 (90%) 0.79 (f)
NCF2 (−153)
AA 0 (0%) 1 (1%) 1.0 (f)
AG 5 (8%) 10 (9%) 0.70 1.0 (f)
GG 61 (92%) 100 (90%) 0.79 (f)
Note: Not all samples amplified at each locus. Comparative analysis
was performed at each of three loci using a 2 analysis (3 × 2 tables
with 2 degrees of freedom) or a Fisher’s exact test (f). MF+ indicates
asymptomatic microfilaremia and CP indicates chronic lymphatic
obstruction/elephantiasis or hydrocele, collectively also known as
chronic pathology.
not identify an association with one of the structural vari-
ants (eg the B, C, and D alleles) nor with haplotypes
(which correlate with measured MBL serum levels).
Nonetheless, our analysis suggests that the promoter
polymorphism could be associated with infection, either
directly or in linkage with another informative locus.
A preliminary analysis was performed examining the
contribution of the two informative loci together. There
was a suggestion of a significant association between the
combination of the presence of the CHIT1 genotype, HH
together with the absence of the XX genotype of MBL2
when uninfected (N) vs infected (MF+ and CP) (7 (11%)
vs 30 (27%) and 59 (89%) vs 83 (73%); P = 0.018). Remark-
ably, no individuals, in either the control or infected
groups, possessed the HH and XX genotypes together.
This observation, in this exploratory analysis, suggests
that the two genotypes could be acting independently.
However, further studies are needed to clarify this point.
We did not observe a significant association for suscep-
tibility to filarial infection for the other four loci studied
MPO, NRAMP, CYBA, and NCF2 (Table 1). Similarly, no
effect was observed with respect to specific outcomes
within the infected group (ie, MF+ and CP) for the other
six genotypes analyzed in this study (data not shown).
A separate analysis was performed on a cohort with
TPE, compared to infected individuals (MF+ and CP)
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Table 2 Genotype distribution of MBL2 in uninfected and infected
subjects in South India
Genotypes Normal Infected group P values N vs
(N) (MF+ and CP) (MF+ and CP)
(n = 67) (n = 113)
Locus Genotype
MBL2
AA 40 (61%) 69 (62%) 0.89
AO* 21 (32%) 38 (34%) 0.68 0.90
OO 5 (8%) 5 (4%) 0.50 (f)
MBL+ (−221)
XX 11 (16%) 4 (4%) 0.004 (f)
XY 22 (33%) 40 (36%) 0.0093 0.87
YY 33 (50%) 68 (61%) 0.22
MBL2 Haplotype
AX/AX 11 (17%) 4 (3%) 0.004 (f)
AX/AY 17 (26%) 29 (26%) 0.98
AX/OY 5 (8%) 11 (10%) 1.0 (f)
AY/AY 12 (18%) 37 (33%) 0.05
AY/OY 16 (24%) 26 (23%) 0.88
OY/OY 5 (8%) 5 (4%) 0.51 (f)
MBL-sufficient
A/A + AY/O 56 (85%) 96 (86%) 0.87MBL-insufficient 10 (15%) 15 (14%)
O/O + AX/O
*O is the usual designation for variant alleles B, C, and D. The
haplotypes for MBL2 include the −221 X/Y promoter variant and
variants of the coding region, known as the structural variants, B,
C and D.29 The latter are inherited independently and so far, have
not been reported to occur simultaneously on the same strand. The
classification of haplotypes as sufficient and insufficient is well
described and separates into two groups, based upon circulating
levels and functional differences in vitro, secondary to a structural
variant (B, C or D).39 Comparative analysis was performed at each
of three loci using a 2 analysis (3 × 2 tables with 2 degrees of
freedom) or a Fisher’s exact test (f). MF+ indicates asymptomatic
microfilaremia and CP indicates chronic lymphatic obstruction/
elephantiasis or hydrocele, collectively also known as chronic path-
ology. Note: Not all samples amplified at each locus.
because the TPE group was collected separately and rep-
resented a concentration of individuals affected by a con-
dition estimated to occur in less than 1 in 100,000. No
association was observed between the six candidate
genes and susceptibility to TPE (data not shown).
Discussion
In a pilot study, we examined six candidate polymorphic
genes, all of which are integral components of
microbicidal pathways in an effort to identify possible
genetic risk factors for human filarial infection. A poly-
morphism in the human CHIT1 gene, which is highly
expressed in phagocytic cells, was associated with sus-
ceptibility to filarial infection in a filarial-endemic region
of South India. However, the variant genotypes of CHIT1
did not associate with the specific, common manifes-
tations of infection, MF+ and CP. Interestingly, we also
observed an association between a MBL2 promoter poly-
morphism and infection with W. bancrofti. The circulating
levels of MBL are affected by the promoter polymor-
phism genotype but the promoter variants do not alter
the function of the protein. It is also plausible that the
promoter variant is in linkage disequilibrium with
another loci on chromosome 10. Follow-up studies are
required to identify and confirm the importance of an
additional locus (or loci). Furthermore, neither CHIT1 nor
MBL2 nor the other four genes studied were associated
with TPE, a rare complication of filariasis.
Chitinases are produced by a large number of species,
including bacteria, fungi, nematodes (including filariae),
and plants.30,31 The microfilarial chitinase is an immuno-
dominant antigen and target of current strategies to
develop candidate vaccines.32–34 The functional contri-
bution of the microfilarial chitinase to infectious patho-
physiology is still not well understood. Still, it is notable
that the microfilarial sheath contains chitin, a putative
target for a human chitotriosidase, encoded by CHIT1.
The human chitotriosidase is produced by macrophages
in large quantities as an acute phase reactant. In vitro,
human chitotriosidase is capable of degrading chitin-
containing pathogens.26,30 Some authors have suggested
that, on the basis of in vitro chitinase activity, it could
play a role in microbicidal activity against complex
pathogens, such as the filarial parasite whose microfil-
arial sheath contains chitin.35 Recently, a mouse chitinase-
like molecule (YM-1) has been shown to be highly
expressed by filarial exposed alternatively activated
macrophages (JE Allen, personal communication). Over-
all, these data suggest a role for these chitinases in modu-
lating the immune response to helminth parasites.
In this context, we were particularly interested in the
investigation of a variant of the human chitotriosidase
gene, CHIT1. The variant H allele of CHIT1 results in a
24-base pair duplication in exon 10 and activates a cryptic
3 splice site, generating an mRNA with an in-frame
deletion of 87 nucleotides.27 Interestingly, there is a
strong correlation between homozygosity for the 24-bp
duplication (HH genotype) and chitotriosidase-
deficiency; in a previously published study, individuals
with the HH genotype (n = 26) demonstrated low or
undetectable levels of circulating chitotriosidase. Further-
more, in vitro activity of the variant protein is markedly
diminished.27 In this regard, our findings suggest that an
alteration in either (or both) circulating levels or altered
function of the chitotriosidase, both described in HH
individuals, could have important consequences for
human filarial infection. Our results indicate that, as
expected, uninfected individuals have a lower frequency
of HH compared to infected individuals, 10% vs 27% (see
Table 1). Although we found an over-representation of
heterozygosity for this gene in the normal control group,
the mechanism of protection is unknown, primarily
because the biological significance of the heterozygous
state is insufficiently characterized. In the course of our
study, we determined the overall distribution of CHIT1
variants and found a major difference in the allelic fre-
quency in the South India population compared to two,
large healthy control groups of North American Caucasi-
ans and African Americans in the USA. Genotype distri-
bution of chitotriosidase among endemic normal in South
India differed from healthy African American (n = 175;
HH 2 (1%), HT 14 (8%), TT 159 (91%), P  0.0001) and
North American Caucasian populations (n = 229; HH 1
(1%), HT 83 (36%), TT 145 (63%), P  0.0001). The HH
genotype is over-represented in normal South Indian
populations compared to other groups studied to date.
The basis for this elevation in HH genotype frequency in
the South India study population is not clear.
The mannose-binding lectin, encoded by the MBL2
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251gene is a C-type collectin that participates in pathogen
recognition, opsonization, phagocytosis and complement
activation.36,37 A common set of structural polymor-
phisms, known as the B, C and D alleles (together known
as the O alleles) within a 15-bp span in exon 1 disrupt
the function of MBL.28,29 The structural change in exon 1
results in a disruption of the binding domain, critical for
oligomerization. Structural variants have been associated
with a wide range of infectious and autoimmune dis-
orders.38–40 In our study, there was no association
observed between the structural variants of MBL2 and
susceptibility to filarial infection. However, we found a
possible association between the promoter polymor-
phism at bp −221 (designated X and Y) and resistance to
infection; filarial infection is less common in individuals
with the XX genotype, associated with decreased circulat-
ing levels of MBL, independent of the structural allele
genotype.
Although we analyzed the haplotypes generated by the
linked MBL2 sites, the total number of patients is small
for this purpose; still, at the locus there might be an
association for the AX/AX haplotype (P = 0.004). These
results suggest that circulating levels of MBL could be
important in the pathogenesis of filarial infection. How-
ever, we did not determine circulating serum levels of
MBL because of the lack of availability of a sufficient
number of samples. Published studies have divided the
common haplotypes into MBL sufficient and insufficient
groups based upon circulating levels as well as in vitro
function of the oligomerized MBL protein.28,39 When we
analyzed the data taking into account MBL-sufficient ver-
sus insufficient halpotypes, the findings were not remark-
able. In the same region of chromosome 10 are located
several other candidate loci, namely SDF1, the ligand for
chemokine receptor 4, CXCR4, which has a polymor-
phism that influences HIV progression.41,42 It is also
plausible that the association with the promoter polymor-
phism, X/Y, has unmasked a second gene, with which
the X/Y variants are in linkage disequilibrium.
We analyzed class II HLA loci, namely, DQA, DQB,
and DRB and did not identify an association with W.
bancrofti infection nor outcomes within the infected group
(data not shown). Our study represents one of several
recent attempts to identify non-HLA associated genetic
risk factors for susceptibility or resistance to parasitic
infection, particularly in endemic areas. A recent report
has shown that there could be genetic predisposition to
microfilaremia and that predisposed subjects might be
genetically unable to mount an efficient immune
response against Loa loa antigens.43,44 Genetic studies in
severe clinical malaria using segregation analysis and
linkage analysis for candidate chromosomal regions have
identified specific loci in the human response to malarial
infection.45–47 In our study, we have identified two candi-
date genes, which could influence susceptibility to filarial
infection. In a pilot analysis of the two informative loci,
it appears that specific genotypes of CHIT1 and MBL2
(X/Y) could contribute to susceptibility to human filarial
infection. Specifically, the presence of HH and absence of
the XX genotype together were associated with increased
susceptibility to infection (7 (11%) vs 30 (27%) and 59
(89%) vs 83 (73%); P = 0.018). Analysis of multiple candi-
date genes should be confirmed in subsequent studies.
The results suggest that small differences in the activity
of one or both of these molecules, over time, could modu-
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late host response and influence infection. Although
speculative, our preliminary results identify an in vivo
role for key molecules that merit further investigation.
Before the results of our study can be applied to clinical
decision making, confirmation of the findings are
required in larger, prospectively recruited studies. Lastly,
further genetic studies utilizing candidate genes derived
from important host defense pathways, such as compo-
nents of the Th1 and Th2 immune response, could be
informative in identifying genetic markers and elucidat-
ing the biology of host response to filarial infection.
Materials and methods
Subjects
Samples for the study populations were collected
between 1987 and 1993 year from South India, an area
endemic with W. bancrofti infection as part of a prospec-
tive study.3 The primary study population consisted of
180 individuals residing in South India. Study subjects
were divided into three groups on the basis of strict para-
sitological evaluation: (i) normal and uninfected, (N, n =
67), (ii) microfilaria and antigen positive without signs or
symptoms of clinical disease (MF+, n = 63) and (iii)
patients with chronic lymphatic dysfunction/ elephan-
tiasis (CP, n = 50). Antifilarial antibodies were measured
in the three groups (eg N, MF+ and CP).48 The geometric
mean titer (g/mL) with the range of measured values
for each group were for N 36.8 (1.6–835), MF+ 137.6 (4.6–
1862), and CP 67.1 (4.5–435.9). There was no difference
in measured IgG antifilarial antibody levels between the
separate groups (data not shown). In addition, occult fil-
arial infection in the normal individuals was excluded by
the absence of circulating filarial antigen using two separ-
ate tests (AMRAD-ICT (Sydney, Australia) and TropBio
(Townsville, Australia)).49,50 A separate collection of
patients with the rare complication, tropical pulmonary
eosinophilia (TPE, n = 36) was analyzed in the second
stage of the study. These samples were collected under
protocols approved by the Institutional Review Board of
the National Institutes of Allergy and Infectious Diseases
(USA) and the Tuberculosis Research Centre (Chennai,
India).
Polymorphism analysis
Genomic DNA was obtained from peripheral blood by
conventional methods. Polymorphism analysis was per-
formed individually for each of six loci. Variants in five
of the six loci have been previously reported. These
included chitotriosidase (CHIT1),26,27 myeloperoxidase
(MPO),24 Nramp-1 intron 4 (NRAMP),25 p22-phox
(CYBA),22,23 and two linked polymorphic sites in exon 1
and the promoter of the mannose-binding lectin
(MBL2).28,29 We also analyzed two novel linked loci in the
promoter of NADPH oxidase p67-phox (NCF2)
(unpublished data). Each polymerase chain reaction
(PCR) based assay was performed in duplicate. Primer
pairs, annealing temperatures, and detection methods for
each locus are shown in Table 3.
Statistical analysis
Distribution of genotypes for each candidate gene was
compared by either the Fisher’s exact test (f) or the chi-
square statistic as appropriate using InStat for Mac-
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Table 3 Detection method for each genotype assay
Genes Primers Annealing temperature Detection method
CHIT1 F: agc tat ctg aag cag aag Size differentiation of PCR product
Exon 10 R: gga gaa gcc ggc aaa gtc 55°C
MPO F: cgg tat agg cac aca atg gtg ag Digest with AciI
G-493A R: gca atg gtt caa gcg att ctt c 58°C
NRAMP F: tct ctg gct gaa ggc tct cc 60°C Digest with ApaI
Intron 4 R: tgt gct atc agt tga gcc tc
CYBA F: tgc ttg tgg gta aac caa ggc cgg tg 60°C Digest with RsaI
C242T R: aac act gag gta agt ggg ggt ggc tcc tgt
NCF2 F: aca agg gtg tgg aaa tca ag 60°C Cycle sequencing
G-153A R: gag cca ggg taa cct tgg
G-149A S: cta ccc aaa ggc agg aaa gtc c
MBL2 F: cct gag tat ggt ggc agc gtc tta ct 58°C Cycle sequencing
Exon 1 R: cag gca gtt tcc tct gga agg
S: act gtg acc tgt gag gat gcc caa aag
−221 X/Y F: cat gga gag aaa gag gaa gct cct
R: tag gca cta tga tga gca gtg gg atc
S: tcc cta agc taa cag gca taa
Intosh Version 2.0 (Graphpad Software, SanDiego, CA,
USA). The analysis of each locus is presented without
correction for multiple statistical significance tests on the
premise that each candidate gene was chosen because of
prior in vitro data and association studies suggesting the
biological significance of variant alleles. Because this is a
pilot study, we interpret the findings as follows to guard
against improper interpretation for specific candidate
genes or genotypes; a P-value (two-tailed) between 0.05
and 0.10 indicates a weak association; a P-value between
0.01 and 0.05 indicates a strong relationship which may
be worth exploring in subsequent or confirmatory stud-
ies; a P-value less than 0.01 indicates a strong association
which is worthy of confirmation.40
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